Skip Navigation LinksHome > March 2011 - Volume 22 - Issue 2 > Time-window Bias in Case-control Studies: Statins and Lung C...
doi: 10.1097/EDE.0b013e3182093a0f
Methods: Brief Report

Time-window Bias in Case-control Studies: Statins and Lung Cancer

Suissa, Samya,b; Dell'Aniello, Sophiea; Vahey, Saraha; Renoux, Christela

Supplemental Author Material
Collapse Box


Time-related biases in cohort studies can produce illusory “beneficial” effects of medications due entirely to an artifact of the analytic design. We describe “time-window bias” in the context of a case-control study, reporting that statin use was associated with a 45% reduction in the incidence of lung cancer. This bias results from the use of time-windows of different lengths between cases and controls to define time-dependent exposures. We illustrate the bias using a population of 365,467 patients from the United Kingdom's General Practice Research Database, including 1786 incident cases of lung cancer during 1998–2004. The case-control approach used in the published study yielded a rate ratio of lung cancer incidence of 0.62 with statin use (95% confidence interval = 0.55–0.71). A case-control approach that properly accounts for time produces a rate ratio of 0.99 (0.85–1.16)—suggesting no benefit of statins on lung cancer risk. We show analytically that the magnitude of the bias is proportional to the ratio of the unequal time-window lengths.

© 2011 Lippincott Williams & Wilkins, Inc.

Twitter  Facebook 


Article Tools


Article Level Metrics